Johnson & Johnson position in the pharmaceutical industry competitive landscape

Detalhes bibliográficos
Autor(a) principal: Gonçalves, Henrique Miguel Da Rocha
Data de Publicação: 2021
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/144696
Resumo: This work project “Johnson & Johnson Place in the Pharmaceutical IndustryCompetitive Landscape” analyses Johnson & Johnson business within the pharmaceutical industry. Given the demand for JNJ products and the growth in revenues brought with COVID-19 due to the Janssen vaccine sales, we estimate a sales growth of 11.4% compared to last year. We will analyze the COVID-19 pandemic current and possible future implications for the industry and the company and compare it with other pharmaceutical companies which are COVID-19 vaccine producers. We will also investigate JNJ most relevant mergers and acquisitions as well as to examine the pharmaceutical industry and the current and future evolution of microeconomic indicators both in the US and the rest of the world. Our valuation of Johnson & Johnson yields a price target of 197.57$ which results in a return of 16.03% and therefore a BUY recommendation
id RCAP_01afeb8202b108d1e8cbb0585204b9fe
oai_identifier_str oai:run.unl.pt:10362/144696
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Johnson & Johnson position in the pharmaceutical industry competitive landscapeValuationEquity researchPharmaceutical industryJnjDomínio/Área Científica::Ciências Sociais::Economia e GestãoThis work project “Johnson & Johnson Place in the Pharmaceutical IndustryCompetitive Landscape” analyses Johnson & Johnson business within the pharmaceutical industry. Given the demand for JNJ products and the growth in revenues brought with COVID-19 due to the Janssen vaccine sales, we estimate a sales growth of 11.4% compared to last year. We will analyze the COVID-19 pandemic current and possible future implications for the industry and the company and compare it with other pharmaceutical companies which are COVID-19 vaccine producers. We will also investigate JNJ most relevant mergers and acquisitions as well as to examine the pharmaceutical industry and the current and future evolution of microeconomic indicators both in the US and the rest of the world. Our valuation of Johnson & Johnson yields a price target of 197.57$ which results in a return of 16.03% and therefore a BUY recommendationAndré, RosárioRUNGonçalves, Henrique Miguel Da Rocha2022-10-14T09:59:40Z2022-01-132021-12-162022-01-13T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/144696TID:203064798enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:24:31Zoai:run.unl.pt:10362/144696Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:51:42.096646Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Johnson & Johnson position in the pharmaceutical industry competitive landscape
title Johnson & Johnson position in the pharmaceutical industry competitive landscape
spellingShingle Johnson & Johnson position in the pharmaceutical industry competitive landscape
Gonçalves, Henrique Miguel Da Rocha
Valuation
Equity research
Pharmaceutical industry
Jnj
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
title_short Johnson & Johnson position in the pharmaceutical industry competitive landscape
title_full Johnson & Johnson position in the pharmaceutical industry competitive landscape
title_fullStr Johnson & Johnson position in the pharmaceutical industry competitive landscape
title_full_unstemmed Johnson & Johnson position in the pharmaceutical industry competitive landscape
title_sort Johnson & Johnson position in the pharmaceutical industry competitive landscape
author Gonçalves, Henrique Miguel Da Rocha
author_facet Gonçalves, Henrique Miguel Da Rocha
author_role author
dc.contributor.none.fl_str_mv André, Rosário
RUN
dc.contributor.author.fl_str_mv Gonçalves, Henrique Miguel Da Rocha
dc.subject.por.fl_str_mv Valuation
Equity research
Pharmaceutical industry
Jnj
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
topic Valuation
Equity research
Pharmaceutical industry
Jnj
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
description This work project “Johnson & Johnson Place in the Pharmaceutical IndustryCompetitive Landscape” analyses Johnson & Johnson business within the pharmaceutical industry. Given the demand for JNJ products and the growth in revenues brought with COVID-19 due to the Janssen vaccine sales, we estimate a sales growth of 11.4% compared to last year. We will analyze the COVID-19 pandemic current and possible future implications for the industry and the company and compare it with other pharmaceutical companies which are COVID-19 vaccine producers. We will also investigate JNJ most relevant mergers and acquisitions as well as to examine the pharmaceutical industry and the current and future evolution of microeconomic indicators both in the US and the rest of the world. Our valuation of Johnson & Johnson yields a price target of 197.57$ which results in a return of 16.03% and therefore a BUY recommendation
publishDate 2021
dc.date.none.fl_str_mv 2021-12-16
2022-10-14T09:59:40Z
2022-01-13
2022-01-13T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/144696
TID:203064798
url http://hdl.handle.net/10362/144696
identifier_str_mv TID:203064798
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138109866115072

Registros relacionados